EP2558592
SINGLE NUCLEOTIDE POLYMORPHISMS THAT PREDICT HCV TREATMENT OUTCOMES
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
11.4.2011EP published:
22.10.2014EP application number:
11717518.2
EPO information:
European Patent Register
Max expiry date:
10.4.2031
Title:
SINGLE NUCLEOTIDE POLYMORPHISMS THAT PREDICT HCV TREATMENT OUTCOMES
Timeline
Today
11.4.2011EP application
22.10.2014EP Publication
Owner
Name:
F. Hoffmann-La Roche AGAddress:
Grenzacherstraße 124, 4070, Basel, CH
Inventor
Name:
CHU, TomAddress:
SunnyvaleCalifornia, US
Name:
ESSIOUX, LaurentAddress:
Attenschwiller, FR
Name:
GERMER, SorenAddress:
MaplewoodNew Jersey, US
Name:
LOPATIN, UriAddress:
San FranciscoCalifornia, US
Name:
SHULMAN, NancyAddress:
Palo AltoCalifornia, US
Name:
THOMMES, JamesAddress:
San FranciscoCalifornia, US
Priority
Number:
323502 PDate:
13.4.2010Country:
US
Classification
Categories:
C12Q 1/68